trastuzumab monoclonal antibody drug. targets the human epidermal growth factor receptor 2 (her2) and is used in the treatment of

antibody biological biosimilar biotech biotechnology breast cancer cd340 disease drug epidermal erbb2 factor generic growth her2 her2neu human immunoglobulin immunology infusion injection inn kinase mab metastatic monoclonal neu nomenclature overexpression peptide protein protooncogene receptor resistance trastuzumab tyrosine